Breaking News

Laureate To Manufacture Arius Antibody

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Laureate Pharma, Inc. has entered into a cGMP contract manufacturing agreement with Arius Research, Inc. to produce Arius’ IgG1 humanized antibody. Arius’ Trop-2 antibody program targets a novel marker that has been linked to aggressive cancers including pancreatic, colon, breast and prostate cancer.     “Our specialized experience in the manufacture of monoclonal antibodies makes us an ideal partner to support Arius and the manufacturing of their Trop-2 Signal Transduction ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters